✦ LIBER ✦

T.I.4 Splice manipulation therapies: Opportunities and challenges

✍ Scribed by S.D. Wilton; S. Fletcher

Book ID: 116793780
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 46 KB
Volume: 18
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2008.06.374

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular and Cellular Therapies: New ch

Molecular and Cellular Therapies: New challenges and opportunities

✍ Wang, Xiangdong; Peer, Dan; Petersen, Bryon 📂 Article 📅 2013 🏛 River Publishers 🌐 English ⚖ 131 KB

Opportunities and challenges in the deve

Opportunities and challenges in the development of targeted therapies

✍ Gabriel N Hortobagyi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Opportunities and challenges for the dev

Opportunities and challenges for the development of pharmacological therapies for obesity treatment

✍ M. A. Cawthorne 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Cell Therapies: Assessing the Patient Ac

Cell Therapies: Assessing the Patient Access Opportunities and Challenges That Lie Ahead

✍ Walker, R.; Mackenzie, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

T.I.4 Cell therapy and muscular dystroph

T.I.4 Cell therapy and muscular dystrophy

✍ Butler-Browne, G. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

The clinical manipulation of angiogenesi

The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies

✍ Thompson, W. Douglas; Li, William W.; Maragoudakis, Michael 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

The ®rst phase of angiogenesis research has provided knowledge of the basic pathobiology of angiogenesis and its manipulation in models, mouse, and man. The ®rst line of therapeutic substances has been devised and is now in clinical trials. New lessons are being learned from clinical observations. U